Clinical significance of KRAS gene mutation and epidermal growth factor receptor expression in Japanese patients with squamous cell carcinoma of the larynx, oropharynx and hypopharynx-Reference-Cited by-同舟云学术

Clinical significance of KRAS gene mutation and epidermal growth factor receptor expression in Japanese patients with squamous cell carcinoma of the larynx, oropharynx and hypopharynx

Published:2012-03-24 Issue:3 Volume:18 Page:454-463
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Fujii Satoshi,Uryu Hideoki,Akashi Ken,Suzuki Kensuke,Yamazaki Manabu,Tahara Makoto,Hayashi Ryuichi,Ochiai Atsushi

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s10147-012-0402-z.pdf

Reference33 articles.

1. Ferlay J, Shin HR, Bray F et al (2010) Estimates of worldwide burden of cancer in 2008. GLOBOCAN 2008. Int J Cancer 127:2893–2917

2. Diaz Jr EM, Sturges EM, Laramore GE (2003) Neoplasms of the head and neck. Holland JF, Frei E (eds) Cancer Medicine. BC Decker Inc., London, pp 1325–1371

3. Ferlay J, Parkin DM, Steliarova-Foucher E (2010) Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46:765–781

4. Matsuda T, Marugame T, Kamo KI et al (2011) The Japan Cancer Surveillance Research Group. Cancer incidence and incidence rates in Japan in 2005: Based on data from 12 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) Project. Jpn J Clin Oncol 41:139–147

5. The Research Group for Population-based Cancer Registration in Japan (2004) Cancer incidence and incidence rates in Japan in 1999: estimates based on data from 11 population-based cancer registries. Jpn J Clin Oncol 34(6):352

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Study of the Acquisition of Sensitivity to Paclitaxel Plus Cetuximab by the Addition of Low-dose Proteasome Inhibitor;Anticancer Research;2022-08-23

2. PTEN Is Activated by the Addition of Cetuximab to Paclitaxel in Oral Squamous Cell Carcinoma;Anticancer Research;2021-07

3. Progress of molecular targeted therapy for head and neck cancer in clinical aspects;Molecular Biomedicine;2021-05-30

4. The PI3K/Akt/mTORC signaling axis in head and neck squamous cell carcinoma: Possibilities for therapeutic interventions either as single agents or in combination with conventional therapies;IUBMB Life;2021-02-04

5. Impact of K-Ras Over-expression in Laryngeal Squamous Cell Carcinoma;In Vivo;2021